Mark C. Clement
Keine laufenden Positionen mehr
Profil
Mark C.
Clement is the founder of Celsis International Ltd.
He served as the Director-Executive Board of Santhera Pharmaceuticals Holding AG from 2000 to 2006.
He was the Chief Executive Officer of Excalibur Fund Managers Ltd.
in 2009 and Chairman of Alderley Analytical Ltd.
He also served as a Non-Executive Director of De Novo Pharmaceuticals Ltd.
Mr. Clement completed his undergraduate degree at the University of Birmingham.
Ehemalige bekannte Positionen von Mark C. Clement
| Unternehmen | Position | Ende |
|---|---|---|
Excalibur Fund Managers Ltd.
 Excalibur Fund Managers Ltd. Investment ManagersFinance Excalibur Fund Managers Ltd (Excalibur) is a venture capital firm founded in 1996 by Christopher Evans. The firm is headquartered in London, United Kingdom. | Präsident | 01.04.2010 |
| SANTHERA PHARMACEUTICALS HOLDING AG | Corporate Officer/Principal | 12.09.2006 |
Alderley Analytical Ltd.
 Alderley Analytical Ltd. Miscellaneous Commercial ServicesCommercial Services Alderley Analytical Ltd. offers bespoke analytical services. It offers assay development and validation, sample analysis, Toxicokinetic and Pharmacokinetic Interpretation, reporting, consulting, and Biopharmaceuticals products. The company was founded by Elizabeth Thomas, Paul Holme, Claire Ayre, and Sally Hannam in 2013 and is headquartered in Alderly Edge, the United Kingdom. | Vorsitzender | - |
Celsis International Ltd.
 Celsis International Ltd. Medical SpecialtiesHealth Technology Celsis International Ltd. develops and supplies medical diagnostic products and laboratory services. The company was founded by Sir Christopher Evans in 1992 and is headquartered in Westminster, the United Kingdom. | Gründer | - |
De Novo Pharmaceuticals Ltd.
 De Novo Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology De Novo Pharmaceuticals Ltd. discovers and develops drugs. It is a novel molecular structure generating drug discovery platform targeting pathogenic bacteria. The firm offers lower cost, rapid, lower molecular weights hits, novel, and patentable hit molecules. The company was founded by David Bailey, Iwan de Esch, and Philip Dean M on April 28, 1999 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Ausbildung von Mark C. Clement
| University of Birmingham | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SANTHERA PHARMACEUTICALS HOLDING AG | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Excalibur Fund Managers Ltd.
Excalibur Fund Managers Ltd. Investment ManagersFinance Excalibur Fund Managers Ltd (Excalibur) is a venture capital firm founded in 1996 by Christopher Evans. The firm is headquartered in London, United Kingdom. | Finance |
De Novo Pharmaceuticals Ltd.
De Novo Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology De Novo Pharmaceuticals Ltd. discovers and develops drugs. It is a novel molecular structure generating drug discovery platform targeting pathogenic bacteria. The firm offers lower cost, rapid, lower molecular weights hits, novel, and patentable hit molecules. The company was founded by David Bailey, Iwan de Esch, and Philip Dean M on April 28, 1999 and is headquartered in London, the United Kingdom. | Health Technology |
Celsis International Ltd.
Celsis International Ltd. Medical SpecialtiesHealth Technology Celsis International Ltd. develops and supplies medical diagnostic products and laboratory services. The company was founded by Sir Christopher Evans in 1992 and is headquartered in Westminster, the United Kingdom. | Health Technology |
Alderley Analytical Ltd.
Alderley Analytical Ltd. Miscellaneous Commercial ServicesCommercial Services Alderley Analytical Ltd. offers bespoke analytical services. It offers assay development and validation, sample analysis, Toxicokinetic and Pharmacokinetic Interpretation, reporting, consulting, and Biopharmaceuticals products. The company was founded by Elizabeth Thomas, Paul Holme, Claire Ayre, and Sally Hannam in 2013 and is headquartered in Alderly Edge, the United Kingdom. | Commercial Services |
